IP Library › Granted Patent US 9,241,916
Granted Patent B2
US 9,241,916 · App. 11/955,680 · Granted Jan 26, 2016

Cognitive performance with sirtuin activators

Inventors: David A. Sinclair (West Roxbury, MA); Li-Huei Tsai (Cambridge, MA); Andre Fischer (Goettingen, DE)
Assignee: President and Fellows of Harvard College
A61K31/122A61K31/015A61K31/05A61K31/352A61K31/415A61K31/473A61K31/519G01N2333/98G01N2800/2814
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,241,916
App. No.
11/955,680
Granted
Jan 26, 2016
Kind
B2
Abstract

Provided herein are methods and compositions for enhancing the cognitive performance of a subject in need thereof. A method may include administering to a subject an agent that increases the level of protein or activity of a sirtuin, such as SIRT1.

Claims (9)

1. A method for improving cognitive performance in a mammalian subject, comprising

(i) determining the cognitive performance of a mammalian subject;

(ii) comparing the cognitive performance of the mammalian subject to a control value; and

(iii) administering to the mammalian subject a SIRT1-activating agent if the cognitive performance of the mammalian subject is lower than the control value, wherein the SIRT1-activating agent is a non-naturally occurring compound, and wherein the SIRT1-activating agent is not a stilbene, flavone or flavonoid.

2. The method of claim 1 , wherein the control value is a value that corresponds to the usual cognitive performance of the mammalian subject or is a value of the average cognitive performance of a group of control mammalian subjects of similar age to that of the mammalian subject.

3. The method of claim 1 , wherein the SIRT1-activating agent is administered orally.

4. The method of claim 1 , further comprising administering to the mammalian subject another agent.

5. The method of claim 4 , wherein the other agent is an anti-oxidant.

6. The method of claim 1 , wherein the mammalian subject is a human.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 19, 2009
From: TSAI, LI-HUEI
To: HOWARD HUGHES MEDICAL INSTITUTE
Reel/Frame 022422/0114 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 19, 2009
From: HOWARD HUGHES MEDICAL INSTITUTE
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 022422/0162 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 19, 2009
From: SINCLAIR, DAVID A.; FISCHER, ANDRE
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 022422/0230 →
CONFIRMATORY LICENSE Recorded Mar 11, 2009
From: HARVARD UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 022375/0111 →
Continuity (4)
Continuation In Part PCTUS2006023239 · Jun 14, 2006
Provisional Application 60690306 · Jun 14, 2005
Provisional Application 60702236 · Jul 25, 2005
Related Publication 20080194803A1 · Aug 14, 2008